Preoperative superselective embolization of skull-base meningiomas: indications and limitations

J Neurooncol. 1998 Oct;40(1):67-71. doi: 10.1023/a:1006196420398.


We evaluated the clinical significance of preoperative superselective embolization for skull-base meningiomas. The subjects consisted of 20 patients with skull-base meningiomas, and were classified into a preoperative embolized group and a non-embolized group. The volume of blood transfused during the operation, the length of the operative procedure and the neurological outcome were compared between the two groups. The results showed that, in tumors smaller than 6 cm, the blood lost during the operation was significantly less in the embolized group. In tumors larger than 6 cm, there was not difference in blood lost, perhaps because larger meningiomas tend to have tiny blood vessels that are unsuitable for preoperative embolization. There was no difference in the length of the operation between the two groups. The embolized group tended to show a better clinical outcome than the non-embolized group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Transfusion
  • Cerebral Hemorrhage / prevention & control
  • Child, Preschool
  • Combined Modality Therapy
  • Embolization, Therapeutic*
  • Female
  • Glasgow Coma Scale
  • Humans
  • Intraoperative Complications / prevention & control
  • Male
  • Meningioma / blood supply
  • Meningioma / surgery*
  • Meningioma / therapy*
  • Middle Aged
  • Preoperative Care
  • Retrospective Studies
  • Skull Neoplasms / blood supply
  • Skull Neoplasms / surgery*
  • Skull Neoplasms / therapy*
  • Treatment Outcome